ID
31072
Description
A Study of PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy (APM4083g); ODM derived from: https://clinicaltrials.gov/show/NCT00517049
Link
https://clinicaltrials.gov/show/NCT00517049
Keywords
Versions (1)
- 7/17/18 7/17/18 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
July 17, 2018
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Non-Hodgkin's Lymphoma NCT00517049
Eligibility Non-Hodgkin's Lymphoma NCT00517049
- StudyEvent: Eligibility
Similar models
Eligibility Non-Hodgkin's Lymphoma NCT00517049
- StudyEvent: Eligibility